Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Cancer control domain
  • 1. Prevention
  • Smoking cessation

Smoking cessation

  • Charts and Tables

    Charts and Tables

    Figure 1.4

    Percentage of recent smokers (aged ≥ 20) reporting quitting smoking in the past two years, by province/territory — 2014 reporting year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    E Interpret with caution owing to large variability in the estimate.

    * Suppressed owing to small numbers.

    Data source: Statistics Canada, Canadian Community Health Survey.

    Data Table

    Province/TerritoryCasesPercent (%)Quality Indicator Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BC154,40023.018.827.2
    MB38,20021.0E15.027.0
    PE5,60019.7E12.826.6
    NB28,80019.114.823.4
    AB139,80018.815.721.9
    QC285,00018.616.420.8
    SK37,40018.514.023.0
    NT2,40018.4E11.525.3
    NS33,80017.312.921.7
    NL18,60016.8E11.522.1
    ON365,80016.314.318.3
    YT1,00013.0E6.819.2
    NU*****

    + Expand Table

    E Interpret with caution owing to large variability in the estimate.

    * Suppressed owing to small numbers.

    Data source: Statistics Canada, Canadian Community Health Survey.

    Figure 1.5

    Percentage of recent smokers (aged ≥ 20) reporting quitting smoking in the past two years, by age group and by sex, Canada — 2014 reporting year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    Data source: Statistics Canada, Canadian Community Health Survey.

    Data Table

    Age Group/SexCasesPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    20-34424,60021.018.723.3
    35-44199,60017.214.619.8
    45-64354,40015.413.617.2
    65+133,00021.018.323.7
    Male614,20017.415.819.0
    Female497,40019.517.721.3

    + Expand Table

    Data source: Statistics Canada, Canadian Community Health Survey.

  • Data specifications

    Data specifications

    Definition: The percentage of recent daily or occasional smokers aged 20 or older who reported quitting smoking in the past two years and no longer smoke

    Numerator: Former smokers aged 20 years and older who were no longer smoking at the time of the survey who have quit in the last 2 years (i.e. recent quitters)

    Denominator: Recent quitters plus current smokers (i.e. those who are currently daily or occasional smokers) aged 20 years and older

    Data source: Statistics Canada, Canadian Community Health Survey (CCHS)

    Measurement timeframe: 2014

    CCHS variables:

    1. Current smoking status
    2. Number of years stopped smoking daily
    3. Number of years stopped smoking completely

    Stratification variables: Province/territory, age group (20-34, 35-44, 45-64, 65+), sex

    Provinces/territories with data available: All provinces/territories

    Notes:

    1. Current smokers and respondents who have never smoked a whole cigarette and respondents who did not smoke a total of 100 cigarettes or more lifetime were excluded from the population.
    2. CCHS data are based on a representative sample which is then extrapolated to the overall population.
  • Related indicators

    Related Indicators

    Second-hand smoke exposure

    Percentage of non-smokers (aged ≥ 12) reporting second-hand smoke exposure, by setting and age group, Canada — 2014 reporting year
    View this indicator
    Lung cancer

    Incidence rates for lung cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year
    View this indicator
    Smoking prevalence

    Percentage of Canadians ( aged >=12) who reported smoking daily or occasionally, Canada — from 2001 to 2015-16 reporting years
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation